Leading Ophthalmologists Highlight the Importance of Illuvien for Chronic DME in the First US Review After the Long Awaited FDA Approval
LONDON, November 5, 2015 /PRNewswire/ — US Ophthalmic Review, the peer-reviewed journal, has published a review highlighting the benefits of Illuvien for chronic DME